Nan Fung Group Holdings
Latest statistics and disclosures from Nan Fung Group Holdings's latest quarterly 13F-HR filing:
- Top 5 stock holdings are EVMN, MPLT, OCS, MDGL, LBRX, and represent 58.72% of Nan Fung Group Holdings's stock portfolio.
- Added to shares of these 4 stocks: EVMN (+$25M), MPLT (+$17M), PCOR, HELP.
- Started 4 new stock positions in PCOR, HELP, EVMN, MPLT.
- Reduced shares in these 2 stocks: JOBY, RKLB.
- Sold out of its position in JOBY.
- Nan Fung Group Holdings was a net buyer of stock by $44M.
- Nan Fung Group Holdings has $112M in assets under management (AUM), dropping by 87.41%.
- Central Index Key (CIK): 0001782539
Tip: Access up to 7 years of quarterly data
Positions held by Nan Fung Group Holdings consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Nan Fung Group Holdings
Nan Fung Group Holdings holds 27 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Evommune Com Shs (EVMN) | 22.1 | $25M | NEW | 1.4M | 17.12 |
|
| Maplight Therapeutics (MPLT) | 15.3 | $17M | NEW | 971k | 17.57 |
|
| Oculis Holding Ordinary Shares (OCS) | 9.2 | $10M | 515k | 19.97 |
|
|
| Madrigal Pharmaceuticals (MDGL) | 6.2 | $6.9M | 12k | 582.34 |
|
|
| Lb Pharmaceuticals Com Shs (LBRX) | 6.0 | $6.7M | 300k | 22.26 |
|
|
| Incyte Corporation (INCY) | 5.2 | $5.8M | 59k | 98.77 |
|
|
| Rhythm Pharmaceuticals (RYTM) | 4.7 | $5.3M | 49k | 107.04 |
|
|
| Beone Medicines Sponsored Ads (ONC) | 4.3 | $4.8M | 16k | 303.81 |
|
|
| Procore Technologies (PCOR) | 3.5 | $3.9M | NEW | 53k | 72.74 |
|
| Cybin Com New (HELP) | 3.4 | $3.8M | NEW | 460k | 8.18 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 2.6 | $2.9M | 14k | 213.24 |
|
|
| ACADIA Pharmaceuticals (ACAD) | 2.5 | $2.8M | 103k | 26.71 |
|
|
| Recursion Pharmaceuticals In Cl A (RXRX) | 2.2 | $2.4M | 595k | 4.09 |
|
|
| D Fluidigm Corp Del (LAB) | 2.2 | $2.4M | 1.9M | 1.28 |
|
|
| Kymera Therapeutics (KYMR) | 2.2 | $2.4M | 31k | 77.81 |
|
|
| Argenx Se Sponsored Adr (ARGX) | 2.1 | $2.4M | 2.8k | 840.95 |
|
|
| Revolution Medicines (RVMD) | 1.4 | $1.5M | 19k | 79.65 |
|
|
| Ishares Ethereum Tr SHS (ETHA) | 1.0 | $1.1M | 51k | 22.43 |
|
|
| Harmony Biosciences Hldgs In (HRMY) | 0.9 | $1.0M | 27k | 37.42 |
|
|
| Ishares Bitcoin Trust Etf Shs Ben Int (IBIT) | 0.7 | $793k | 16k | 49.65 |
|
|
| Rani Therapeutics Hldgs Com Cl A (RANI) | 0.6 | $666k | 494k | 1.35 |
|
|
| Replimune Group (REPL) | 0.6 | $619k | 64k | 9.72 |
|
|
| Entrada Therapeutics (TRDA) | 0.5 | $505k | 49k | 10.28 |
|
|
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.4 | $488k | 69k | 7.08 |
|
|
| Bolt Biotherapeutics Com New (BOLT) | 0.3 | $319k | 58k | 5.47 |
|
|
| Rocket Lab Corp (RKLB) | 0.2 | $267k | -87% | 3.8k | 69.76 |
|
| Bolt Projs Hldgs Com New (BSLK) | 0.0 | $32k | 41k | 0.80 |
|
Past Filings by Nan Fung Group Holdings
SEC 13F filings are viewable for Nan Fung Group Holdings going back to 2021
- Nan Fung Group Holdings 2025 Q4 filed Feb. 13, 2026
- Nan Fung Group Holdings 2025 Q3 filed Nov. 13, 2025
- Nan Fung Group Holdings 2025 Q2 filed Aug. 13, 2025
- Nan Fung Group Holdings 2025 Q1 filed May 14, 2025
- Nan Fung Group Holdings 2024 Q4 filed Feb. 13, 2025
- Nan Fung Group Holdings 2024 Q3 filed Nov. 13, 2024
- Nan Fung Group Holdings 2024 Q2 filed Aug. 13, 2024
- Nan Fung Group Holdings 2024 Q1 filed May 14, 2024
- Nan Fung Group Holdings 2023 Q4 filed Feb. 13, 2024
- Nan Fung Group Holdings 2023 Q3 filed Nov. 13, 2023
- Nan Fung Group Holdings 2023 Q2 filed Aug. 11, 2023
- Nan Fung Group Holdings 2023 Q1 filed May 12, 2023
- Nan Fung Group Holdings 2022 Q4 filed Feb. 13, 2023
- Nan Fung Group Holdings 2022 Q3 filed Nov. 10, 2022
- Nan Fung Group Holdings 2022 Q2 filed Aug. 12, 2022
- Nan Fung Group Holdings 2022 Q1 filed May 13, 2022